Wednesday, February 29, 2012

Pfizer Pulls US Bid To Market Antidepressant To Treat Menopausal Symptoms | Fox Business

Pfizer Inc. (PFE) has withdrawn an application seeking U.S. regulatory approval to market its antidepressant Pristiq as a treatment for certain menopause-related symptoms in women.

The U.S. Food and Drug Administration in September declined to approve Pfizer's bid to expand the drug's uses to include relief of moderate-to-severe vasomotor symptoms associated with menopause, such as hot flashes and night sweats.

Posted via email from Jack's posterous

No comments: